Drugs / Tissue sealant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02952365 | Oct 2016 → May 2017 | — | Stanford University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tissue sealant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02952365 ↗ |
| Route | Topical | “Tissue sealant will be applied at to the edge of the LASIK flap at the conclusion of the surgery.” NCT02952365 ↗ |